Pharmabiz

TNCDA files complaint against Tata 1MG for drug law violations, joins AIOCD’s call for national bandh

TNCDA files complaint against Tata 1MG for drug law violations, joins AIOCD’s call for national bandh: Peethaambaran Kunnathoor, Chennai Monday, April 6, 2026, 08:00 Hrs [IST] T ...
Pharmabiz

Recent advances in genetics to identify DNA changes directly linked to cancer development in CRC

Recent advances in genetics to identify DNA changes directly linked to cancer development in CRC: Shardul Nautiyal, Mumbai Monday, April 6, 2026, 08:00 Hrs [IST] Recent advances i ...
Pharmabiz

Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation

Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation: Gireesh Babu, New Delhi Monday, April 6, 2026, 08:00 Hrs [IST] Taking note that no actual expenditur ...
Pharmabiz

DTAB recommends revision of microbial contamination limits in Schedule M

DTAB recommends revision of microbial contamination limits in Schedule M: Gireesh Babu, New Delhi Monday, April 6, 2026, 08:00 Hrs [IST] The Drugs Technical Advisory Board has agr ...
Pharmabiz

KCDA opposes mandatory geo-tagging of pharmacy outlets, cites lack of legal backing

KCDA opposes mandatory geo-tagging of pharmacy outlets, cites lack of legal backing: Nandita Vijayasimha, Bengaluru Monday, April 6, 2026, 08:00 Hrs [IST] The Karnataka Chemists & ...
PharmabizOpinion

KPRDO concerned over escalating conflict in West Asia impacting pharmacy trade

KPRDO concerned over escalating conflict in West Asia impacting pharmacy trade: Nandita Vijayasimha, Bengaluru Monday, April ...
Pharmabiz

Ascletis completes enrollment in US phase IIa study of small molecule oral GLP-1R agonist, ASC30 to treat obesity

Ascletis Pharma Inc., a fully integrated biotechnology company, announces completion of enrollment in its US 13-week phase IIa study evaluating ASC30, a small molecule oral GLP-1 receptor (GLP-1R) ...